Rational phytotherapy: a physicians' guide to herbal medicine
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English German |
| Veröffentlicht: |
Berlin [u.a.]
Springer
2001
|
| Ausgabe: | 4. ed., fully rev. and expanded |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben. - Dt. Ausg. u.d.T.: Schulz, Volker: Rationale Phytotherapie |
| Beschreibung: | XIX, 383 S. Ill., graph,Darst. |
| ISBN: | 3540670963 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV021788672 | ||
| 003 | DE-604 | ||
| 005 | 20150512 | ||
| 007 | t | ||
| 008 | 061030s2001 gw a||| |||| 00||| eng d | ||
| 016 | 7 | |a 959084703 |2 DE-101 | |
| 020 | |a 3540670963 |c Pp. : DM 78.00 |9 3-540-67096-3 | ||
| 035 | |a (OCoLC)44267919 | ||
| 035 | |a (DE-599)BVBBV021788672 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 1 | |a eng |h ger | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-19 | ||
| 050 | 0 | |a RM666.H33 | |
| 082 | 0 | |a 615/.321 |2 21 | |
| 084 | |a VS 9450 |0 (DE-625)147729:253 |2 rvk | ||
| 100 | 1 | |a Schulz, Volker |d 1942- |e Verfasser |0 (DE-588)1070874647 |4 aut | |
| 245 | 1 | 0 | |a Rational phytotherapy |b a physicians' guide to herbal medicine |c Volker Schulz ; Rudolf Hänsel ; Varro E. Tyler |
| 250 | |a 4. ed., fully rev. and expanded | ||
| 264 | 1 | |a Berlin [u.a.] |b Springer |c 2001 | |
| 300 | |a XIX, 383 S. |b Ill., graph,Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben. - Dt. Ausg. u.d.T.: Schulz, Volker: Rationale Phytotherapie | ||
| 650 | 2 | |a Extraits de plantes - usage thérapeutique | |
| 650 | 4 | |a Herbes - Emploi en thérapeutique | |
| 650 | 2 | |a Phytothérapie | |
| 650 | 7 | |a Phytothérapie |2 ram | |
| 650 | 2 | |a Plantes médicinales | |
| 650 | 7 | |a Plantes médicinales |2 ram | |
| 650 | 4 | |a Herbal Medicine | |
| 650 | 4 | |a Herbs |x Therapeutic use | |
| 650 | 4 | |a Plant Extracts |x therapeutic use | |
| 650 | 4 | |a Plants, Medicinal | |
| 650 | 0 | 7 | |a Phytotherapie |0 (DE-588)4045998-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Phytopharmakon |0 (DE-588)4115561-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Phytopharmakon |0 (DE-588)4115561-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Phytotherapie |0 (DE-588)4045998-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Hänsel, Rudolf |d 1920-2018 |e Verfasser |0 (DE-588)115453075 |4 aut | |
| 700 | 1 | |a Tyler, Varro E. |e Verfasser |4 aut | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015001354&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015001354 | ||
Datensatz im Suchindex
| _version_ | 1804135697752260608 |
|---|---|
| adam_text | VOLKER SCHULZ RUDOLF HANSEL VARRO E. TYLER RATIONAL PHYTOTHERAPY A
PHYSICIANS GUIDE TO HERBAL MEDICINE FOURTH EDITION, FULLY REVISED AND
EXPANDED WITH 90 FIGURES AND 50 TABLES SPRINGER 1 MEDICINAL PLANTS,
PHYTOMEDICINES, AND PHYTOTHERAPY 1 1.1 COMMON ROOTS OF PHARMACOTHERAPY 1
1.2 MAKING MEDICINES SAFER BY ISOLATING AND MODIFYING PLANT CONSTITUENTS
2 1.3 PHARMACEUTICAL PREPARATION OF PHYTOMEDICINES .. 4 1.3.1 WHAT ARE
EXTRACTS? 5 1.3-2 STANDARDIZATION OF EXTRACTS 5 1.3.2.1 QUALITY OF THE
HERBAL MATERIAL 6 1.3.2.2 PRODUCTION METHODS 6 1.3.2.3 ADJUSTMENT OF
QUALITY 7 1.3.2.4 ANALYTICAL QUALITY CONTROL 8 1.4 PHYTOMEDICINES 9
1.4.1 LIQUID DOSAGE FORMS 9 1.4.1.1 TINCTURES, GLYCERITES, AND RELATED
PRODUCTS 9 1.4.1.2 SYRUPS 10 1.4.1.3 MEDICINAL OILS 10 1.4.1.4 MEDICINAL
SPIRITS 11 1.4.1.5 PLANT JUICES 11 1.4.2 SOLID DOSAGE FORMS 11 1.4.2.1
GRANULES 12 1.4.2.2 UNCOATED TABLETS 12 1.4.2.3 COATED TABLETS 12
1.4.2.4 CAPSULES 12 1.4.2.5 LOZENGES 13 1.4.3 PACKAGING , 13 1.4.4
HERBAL COMBINATION PRODUCTS , 14 1.5 PHYTOTHERAPY 16 1.5.1
PHARRIIACOLOGIC CHARACTERISTICS 16 1.5.1.1 THERAPEUTIC RANGE 16 1.5.1.2
ONSET OF ACTION 16 ,1.5.2 ..-PHARMACOLOGIC AND CLINICAL RESEARCH 17
1.5.3 INDICATIONS FOR THE USE OF PHYTOMEDICINES 19 1.5.4 WHAT PHYSICIANS
REQUIRE FROM PHYTOMEDICINES . . 20 1.55 HOPES AND EXPECTATIONS OF THE
PATIENTS 22 1.5.6 BENEFITS AND RISKS OF PHYTOMEDICINES COMPARED WITH
OTHER THERAPIES 23 XI 1.6 MEDICINAL TEAS TODAY 25 1.6.1 ORIGIN OF THE
WORD TEA. MEDICINAL AND NONMEDICINAL TEAS 25 1.6.2 MEDICINAL TEAS AND
THEIR ACTIONS 27 1.6.3 VARIOUS FORMS OF MEDICINAL TEAS 30 1.6.3.1
MIXTURES OF CUT AND DRIED HERBS 31 1.6.3.2 TEA-BAG TEAS 31 1.6.3.3
SOLUBLE TEAS 31 1.6.4 STANDARD APPROVAL FOR TEA MIXTURES 31 1.6.5 TEAS
COMPOUNDED AS PRESCRIBED BY A PHYSICIAN . . 32 1.6.6 GUIDELINES FOR TEA
PREPARATION 34 1.6.7 TEAS FOR INFANTS AND CHILDREN 35 1.6.8 ADVERSE
EFFECTS AND RISKS . 36 2 CENTRAL NERVOUS SYSTEM 41 2.1 GINKGO IN THE
TREATMENT OF COGNITIVE DEFICIENCY 42 2.1.1 INTRODUCTION 42 2.1.2
BOTANICAL DESCRIPTION 43 2.1.3 CRUDE DRUG AND EXTRACT 44 2.1.4 KEY
CONSTITUENTS, ANALYSIS, PHARMACOKINETICS ... 44 2.1.5 PHARMACOLOGY AND
TOXICOLOGY 45 2.1.6 CLINICAL EFFICACY IN PATIENTS WITH COGNITIVE
DEFICIENCY 46 2.1.7 INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS
52 2.1.8 THERAPEUTIC SIGNIFICANCE 53 2.1.9 DRUG PRODUCTS 54 2.2 ST.
JOHN S WORT AS AN ANTIDEPRESSANT 57 2.2.1 INTRODUCTION 57 2.2.2
BOTANICAL DESCRIPTION 57 2.23 ~ CRUDE DRUG AND EXTRACT 58 2.2.4 KEY
CONSTITUENTS, ANALYSIS, PHARMACOKINETICS ... 59 2.2.5 PHARMACOLOGY 6L
2.2.5.1 BIOCHEMICAL MODELS 6L 2.2.5.2 BEHAVIORAL MODELS IN ANIMALS 63
2.2.6 TOXICOLOGY, PHOTOSENSITIZATION 64 2.2.7 CLINICAL EFFICACY IN
DEPRESSED PATIENTS 64 2.2.8 INDICATIONS,- DOSAGES, RISKS, AND
CONTRAINDICATIONS 70 2.2.9 , THERAPEUTIC SIGNIFICANCE 72 2.2.10 * / DRUG
PRODUCTS 73 2.3 KAVA AS AN ANXIOLYTIC 78 2.3.1 INTRODUCTION 78 2.3.2
BOTANICAL DESCRIPTION 78 2.3.3 CRUDE DRUG AND EXTRACT 78 XII TABLE OF
CONTENTS 2.3.4 KEY CONSTITUENTS, ANALYSIS, PHARMACOKINETICS ... 79 2.3.5
PHARMACOLOGY AND TOXICOLOGY 80 2.3.6 CLINICAL EFFICACY 81 2.3.7 SIDE
EFFECTS AND RISKS 84 2.3.8 INDICATIONS AND DOSAGES 85 2.3.9 THERAPEUTIC
SIGNIFICANCE 85 2.3.10 DRUG PRODUCTS 85 2.4 RESTLESSNESS AND SLEEP
DISTURBANCES 87 2.4.1 VALERIAN 87 2.4.1.1 MEDICINAL PLANT 87 2.4.1.2
CRUDE DRUG AND EXTRACT 87 2.4.1.3 KEY CONSTITUENTS, ANALYSIS,
PHARMACOKINETICS ... 88 2.4.1.4 PHARMACOLOG Y AND TOXICOLOGY 89 2.4.1.5
PHARMACOLOGIC EFFECTS IN HUMANS AND CLINICAL EFFICACY IN PATIENTS 91
2.4.1.6 INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS 96 2.4.1.7
THERAPEUTIC SIGNIFICANCE 97 2.4.2 HOPS, LEMON BALM, PASSION FLOWER, AND
LAVENDER 97 2.4.2.1 HOP STROBILES AND HOP GLANDS 98 2.4.2.2 BALM LEAVES
99 2.4.2.3 PASSION FLOWER 99 2.4.2.4 LAVENDER 100 2.4.3 SEDATIVE TEAS
102 2.4.4 DRUG PRODUCTS 103 3 CARDIOVASCULAR SYSTEM 107 3.1 HEART
FAILURE AND CORONARY INSUFFICIENCY 107 3.1.1 HAWTHORN 108 3.1.1.1
INTRODUCTION 108 3.1.1.2 MEDICINAL PLANT 109 3.1.1.3 CRUDE DRUG AND
EXTRACT 109 3.1.1.4 KEY CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . . .
109 3.1.1.5 PHARMACOLOGY 110 3.1.1.6 TOXICOLOGY 113 3.1.1.7 CLINICAL
EFFICACY 114 3.1.1.8 INDICATIONS. DOSAGES, RISKS, AND CONTRAINDICATIONS
117 3.1.1.9 THERAPEUTIC SIGNIFICANCE 118 3.1.1.10 DRUG PRODUCTS 118
3.1.2 HERBS CONTAINING DIGITALOIDS 119 3,.1.2.1 FALSE HELLABORE 120
4. 22 LILY-OF-THE-VALLEY 120 3.1.2.3 SQUILL POWDER 121 3.1.2.4 OLEANDER
LEAVES 121 3-1.2.5 DRUG PRODUCTS 122 3.1.3 OTHER CARDIOACTIVE PLANT
DRUGS . . ... . 122 TABLE OF CONTENTS XIII 3.2 HYPOTENSION AND
HYPERTENSION 124 3.2.1 PHYTOTHERAPY OF HYPOTENSION 124 3.2.1.1
CAFFEINE-CONTAINING HERBS AND BEVERAGES 125 3.2.1.2 ESSENTIAL OILS 126
3.2.2 PHYTOTHERAPY OF HYPERTENSION 126 3.3 ATHEROSCLEROSIS AND ARTERIAL
OCCLUSIVE DISEASE . . 128 3.3.1 GARLIC 128 3.3.1.1 HISTORICAL BACKGROUND
128 3.3.1.2 BOTANICAL DESCRIPTION 129 3.3.1.3 CRUDE DRUG 130 3.3.1.4 KEY
CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . . . 131 3-3.1-5 EXPERIMENTAL
PHARMACOLOGY 133 3.3.1.5.1 EFFECTS ON ATHEROGENESIS AND LIPID METABOLISM
135 3-3.1.5.2 EFFECTS ON VASCULAR RESISTANCE, FIBRINOLYSIS, AND PLATELET
AGGREGATION 135 3.3-1-5.3 CARDIOPROTECTIVE AND ANTIOXIDATIVE EFFECTS 137
3.3-1-5.4 OTHER ACTIONS 137 3.3^1-6 TOXICOLOGY 138 3-3-1-7 CLINICAL
STUDIES 138 3.3.1.7.1 REDUCTION OF ELEVATED BLOOD LIPIDS 140 3.3.1.7.2
BLOOD PRESSURE REDUCTION 141 3.3.1.7.3 INHIBITING THE PROGRESSION OF
ATHEROSCLEROSIS IN HUMANS 142 3.3-1.7.4 OTHER CLINICAL STUDIES 144
3.3.1.8 SIDE EFFECTS AND GARLIC ODOR 144 3.3.1.9 INDICATIONS, DOSAGES,
RISKS, AND CONTRAINDICATIONS 146 3.3.1.10 THERAPEUTIC SIGNIFICANCE 147
3-3-1.11 DRUG PRODUCTS 148 3.3.2 GINGKO SPECIAL EXTRACT FOR PERIPHERAL
ARTERIAL OCCLUSIVE DISEASE 152 3R3-3 OTHER HERBS WITH
ANTIATHEROSCLEROTIC PROPERTIES 155 3-3-3.1 RED YEAST RICE 156 3.4
CHRONIC VENOUS INSUFFICIENCY 158 3.4.1 HORSE CHESTNUT SEED EXTRACT 158
3.4.1.1 INTRODUCTION 158 3.4.1.2 CRUDE DRUG-AND EXTRACT 159 3.4.1.3
CHEMISTRY AND PHARMACOKINETICS OF AESCIN 160 3:4.1.4 PHARMACOLOGY 160
3.4.1.5/ TOXICOLOGY 161 3.4.176 ACTIONS AND EFFICACY IN SUBJECTS AND
PATIENTS . . . 161 3.4.1.6.1 STUDIES IN HEALTHY SUBJECTS 161 3.4.1.6.2
THERAPEUTIC STUDIES IN PATIENTS 161 3.4.1.7 INDICATIONS, DOSAGES, RISKS,
AND CONTRAINDICATIONS 165 XIV TABLE OF CONTENTS 3.4.1.8 THERAPEUTIC
SIGNIFICANCE 165 3.4.2 TOPICAL VENOUS REMEDIES 166 3.4.3 DRUG PRODUCTS
167 4 RESPIRATORY SYSTEM 169 4.1 COLD SYNDROME (FLULIKE INFECTION) 169
4.1.1 RISK FACTORS 169 4.1.2 VIRUSES AND HOST DEFENSES 170 4.2 GENERAL
PHYTOTHERAPEUTIC MEASURES 171 4.2.1 TEAS FOR COLD RELIEF 171 4.2.1.1
ELDER FLOWERS 171 4.2.1.2 LINDEN FLOWERS 172 4.2.1.3 MEADOWSWEET FLOWERS
173 4.2.1.4 WILLOW BARK AND SALICYLATES 174 4.2.1.5 TEA FORMULAS 174
4.2.2 ESSENTIAL OILS 176 4.2.2.1 NASAL OINTMENTS AND NOSEDROPS 176
4.2.2.2 INHALATION THERAPY 177 4.2.2.3 LOZENGES, TROCHES AND GARGLES 178
4.3 HERBAL COUGH REMEDIES 180 4.3.1 MUCILAGINOUS HERBS 180 4.3.2
ESSENTIAL OILS IN COUGH REMEDIES 181 4.3-3 EPHEDRA 182 4.4 HERBAL
EXPECTORANTS 18 4 4.4.1 MECHANISMS OF ACTION 184 4.4.1.1 REDUCTION OF
MUCUS VISCOSITY BY WATER 184 4.4.1.2 NEURAL MECHANISM BASED ON THE
GASTROPULMONARY REFLEX 185 4.4.1.3 LIQUEFACTION OF SECRETIONS BY DIRECT
ACTION ON THE BRONCHIAL GLANDS 185 4.4.2 SAPONIN-CONTAINING HERBS 186
4.4.3 ESSENTIAL OILS AS EXPECTORANTS 189 4.4.3.1 DOSAGE FORMS 190
4.4.3.2 CINEOLE (EUCALYPTOL) 192 4.4.3.3 MYRTOL 192 4.4.3.4 ANISE OIL
AND ANETHOLE 193 4.4.4 LICORICE ROOT 194 4.4.5 SUGGESTED FORMULATIONS
195 4.5 PHYTOTHERAPY OF SINUSITIS 197 -4.6 DRUG PRODUCTS 198 TABLE OF
CONTENTS XV 5 DIGESTIVE SYSTEM 203 5.1 ANOREXIA AND DYSPEPSIA 203 5.1.1
INTRODUCTION 203 5.1.2 BITTER HERBS (BITTERS) 204 5.1.2.1 WORMWOOD
(ABSINTH) 206 5.1.2.2 OTHER BITTER HERBS 207 5.1.3 BILIARY REMEDIES
(CHOLAGOGUES) 209 5.1.3.1 ARTICHOKE LEAVES 210 5.1.3.2 OTHER CHOLAGOGUES
213 5.1.4 DIGESTIVE ENZYMES 214 5.1.5 SUGGESTED FORMULATIONS 215 5.1.6
DRUG PRODUCTS 217 5.2 BLOATING AND FLATULENCE 218 5.2.1 DEFINITION AND
ACTIONS OF CARMINATIVES 219 5.2.2 TYPICAL CARMINATIVE HERBS 219 5.2.3
SUGGESTED FORMULATIONS 220 5.3 GASTRITIS AND ULCER DISEASE 222 5.3.1
CHAMOMILE 223 5.3.2 LICORICE ROOT 223 5.3.3 DRUG PRODUCTS 224 5.4
IRRITABLE BOWEL SYNDROME 225 5.4.1 SYMPTOMS, EPIDEMIOLOGY, AND
APPROACHES TO TREATMENT 225 5.4.2 PEPPERMINT 226 5.4.2.1 CRUDE DRUG AND
CONSTITUENTS T : 226 5.4.2.2 PEPPERMINT OIL 226 5.4.2.3 PHARMACOKINETICS
227 5.4.2.4 PHARMACOLOGY 228 5.4.2.5 THERAPEUTIC EFFICACY 228 5.4.2.6
RISKS AND SIDE EFFECTS 239 5.4.2.7 INDICATIONS, DOSAGES, AND
CONTRAINDICATIONS .... 230 5.5 ACUTE DIARRHEA 232 5.5.1
TANNIN-CONTAINING HERBS 232 5.5.1.1 GREEN AND BLACK TEA 233 5.5.1.2
OTHER TANNIN-CONTAINING HERBS 234 5.5.1.3 TANNIC ACID AND ALBUMIN
TANNATE 235 5.5.2 PECTINS . ; :-. 236 5.5.3 LIVE DRIED YEAST 236 5.5.3-1
PHARMACOLOGY AND TOXICOLOGY 237 5.5.3.2 THERAPEUTIC EFFICACY 237 5.5.3-3
INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS 238 5.5.4 OTHER
HERBAL ANTIDIARRHEALS 238 5.5.5 SUGGESTED FORMULATIONS 240 XVI TABLE OF
CONTENTS 5.6 CONSTIPATION 241 5.6.1 SYMPTOMS, CAUSES, GENERAL MEASURES
241 5.6.2 BULK-FORMING AGENTS 242 5.6.2.1 MECHANISM OF ACTION 242
5.6.2.2 LINSEED 244 5.6.2.3 WHEAT BRAN 246 5.6.2.4 PSYLLIUM SEED AND
HUSK 247 5.6.2.5 AGAR AND KARAYA GUM 248 5.6.3 OSMOTIC AGENTS 248 5.6.4
ANTHRANOID-CONTAINING HERBS 249 5.6.4.1 RHUBARB ROOT 251 5.6.4.2
BUCKTHORN BARK 252 5.6.4.3 SENNA PODS AND LEAVES 253 5.6.4.4 ALOE 253
5.6.5 CASTOR OIL 254 5.6.6 SUGGESTED FORMULATIONS 255 5.7 LIVER DISEASES
257 5.7.1 MILK THISTLE FRUITS, SILYMARIN 258 5.7.1.1 MEDICINAL PLANT AND
CRUDE DRUG 258 5.7.1.2 COMPONENTS AND ACTIVE CONSTITUENTS 259 5.7.1.3
PHARMACOKINETICS 259 5.7.1.4 PHARMACOLOGY AND TOXICOLOGY 259 5.7.1.5
THERAPEUTIC EFFICACY IN CHRONIC LIVER DISEASES . . 260 5.7.1.6 USE IN
MUSHROOM POISONING 261 5.7.1.7 INDICATIONS, DOSAGES, RISKS, AND
CONTRAINDICATIONS 262 5.7.2 SOYBEAN PHOSPHOLIPIDS 262 5.7.3 DRUG
PRODUCTS 263 6 URINARY TRACT 265 6.1 INFLAMMATORY DISEASES OF THE
URINARY TRACT .... 265 6.1.1 UVA URSI LEAVES 266 6.1.2 PETASITE RHIZOME
268 6.2 BENIGN PROSTATIC HYPERPLASIA 268 6.2.1 SAW PALMETTO BERRIES 270
6.2.2 NETTLE ROOT 274 6.2.3 PUMPKIN SEEDS 275 6.2.4 GRASS POLLENS 276
6.2.5 PHYTOSTEROLS FROM HYPOXIS ROOPERI 277 6.2.6 PYGEUM 278 / 6.3
THERAPEUTIC SIGNIFICANCE 278 6.4 DRUG PRODUCTS OTHER THAN TEAS 27 9 6.5
BLADDER AND KIDNEY TEAS 280 TABLE OF CONTENTS XVII 7. GYNECOLOGIC
INDICATIONS FOR HERBAL REMEDIES . . . 285 7.1 CHASTEBERRY 286 7.2 BLACK
COHOSH 289 7.3 PHYTOESTROGENS 291 7.4 OTHER HERBS 293 7.5 THERAPEUTIC
SIGNIFICANCE 295 7.6 DRUG PRODUCTS 295 8 SKIN,TRAUMA, RHEUMATISM, AND
PAIN 299 8.1 DOSAGE FORMS AND PREPARATIONS 299 8.2 INFLAMMATIONS AND
INJURIES OF THE SKIN 301 8.2.1 CHAMOMILE FLOWERS 301 8.2.1.1 CRUDE DRUG,
CONSTITUENTS, AND PREPARATIONS .... 302 8.2.1.2 PHARMACOLOGY AND
TOXICOLOGY 304 8.2.1.3 THERAPEUTIC EFFICACY 305 8.2.1.4 INDICATIONS,
DOSAGES, SIDE EFFECTS, AND RISKS .... 305 8.2.2 WITCH HAZEL AND OTHER
TANNIN-CONTAINING HERBS 306 8.2.3 EVENING PRIMROSE OIL 308 8.2.4 OTHER
DERMATOLOGIC HERBS 310 8.3 POST-TRAUMATIC AND POSTOPERATIVE CONDITIONS .
. . 313 8.3.1 BROMELAIN 313 8.3.2 COMFREY 314 8.3.3 ARNICA 314 8.4
RHEUMATIC CONDITIONS AND DEGENERATIVE JOINT DISEASES 316 8.4.1 DEVIL S
CLAW 316 8.4.2 WILLOW BARK, ASH, ASPEN 318 8.4.3 NETTLE TOPS 319 8.4.4
BOSWELLIA SERRATA 319 8.5 TREATMENT OF PAIN 320 8.5.1 PEPPERMINT OIL AND
TENSION HEADACHE 320 8.5.2 CAPSICUM (PAPRIKA) FOR LOCAL PAIN RELIEF 322
8.6, FORMULATIONS 325 8.7 / DRUG PRODUCTS 326 XVIII TABLE OF CONTENTS 9
AGENTS THAT INCREASE RESISTANCE TO DISEASES .... 331 9.1 ADAPTOGENS 331
9.1.1 GINSENG 332 9.1.1.1 PLANT, CRUDE DRUG, AND CONSTITUENTS 332
9.1.1.2 PHARMACOLOGY AND TOXICOLOGY 333 9.1.1.3 CLINICAL STUDIES IN
HUMANS 334 9.1-1.4 INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS
334 9.1.2 ELEUTHEROCOCCUS ROOT 335 9.1-3 OTHER ADAPTOGENIC DRUGS 336
9.1.3.1 CORDYCEPS 336 9.1.3.2 ASHWAGANDHA 337 9.1.3.3 GOTU KOLA 337
9.1.3.4 ASTRAGALUS 338 9.1.3.5 CAT S CLAW 338 9-1.3.6 BOTANICAL
ANTIOXIDANTS (GRAPE SEED, GREEN TEA, PINE BARK) 339 9-1-3.6.1
PHARMACOLOGY AND TOXICOLOGY 339 9-1-3.6.2 CLINICAL AND EPIDEMIOLOGICAL
STUDIES 340 9-1-3.6.3 INDICATIONS AND DOSAGE 341 9.2 IMMUNE STIMULANTS
341 9.2.1 CONEFLOWER (ECHINACEA) 342 9.2.1.1 PLANT, CRUDE DRUG, AND
CONSTITUENTS 342 9.2.1.2 PHARMACOLOGY AND TOXICOLOGY 343 9-2.1.3 STUDIES
ON THERAPEUTIC EFFICACY 344 9-2.1.4 INDICATIONS, DOSAGES, AND RISKS 346
9.2.2 EUROPEAN MISTLETOE 347 9.2.2.1 PLANT, CONSTITUENTS, AND ACTIONS
347 9.2.2.2 CLINICAL EFFICACY STUDIES 349 9.2.2.3 INDICATIONS, DOSAGES,
AND RISKS 350 9.2.3 MEDICINAL YEASTS 350 9.2.4 GOLDENSEAL 351 9.3
THERAPEUTIC SIGNIFICANCE 352 10 APPENDIX THE 100 MOST COMMONLY
PRESCRIBED HERBAL MEDICATIONS IN GERMANY 357 SUBJECT INDEX 369 TABLE OF
CONTENTS XIX
|
| adam_txt |
VOLKER SCHULZ RUDOLF HANSEL VARRO E. TYLER RATIONAL PHYTOTHERAPY A
PHYSICIANS' GUIDE TO HERBAL MEDICINE FOURTH EDITION, FULLY REVISED AND
EXPANDED WITH 90 FIGURES AND 50 TABLES SPRINGER 1 MEDICINAL PLANTS,
PHYTOMEDICINES, AND PHYTOTHERAPY 1 1.1 COMMON ROOTS OF PHARMACOTHERAPY 1
1.2 MAKING MEDICINES SAFER BY ISOLATING AND MODIFYING PLANT CONSTITUENTS
2 1.3 PHARMACEUTICAL PREPARATION OF PHYTOMEDICINES . 4 1.3.1 WHAT ARE
EXTRACTS? 5 1.3-2 STANDARDIZATION OF EXTRACTS 5 1.3.2.1 QUALITY OF THE
HERBAL MATERIAL 6 1.3.2.2 PRODUCTION METHODS 6 1.3.2.3 ADJUSTMENT OF
QUALITY 7 1.3.2.4 ANALYTICAL QUALITY CONTROL 8 1.4 PHYTOMEDICINES 9
1.4.1 LIQUID DOSAGE FORMS 9 1.4.1.1 TINCTURES, GLYCERITES, AND RELATED
PRODUCTS 9 1.4.1.2 SYRUPS 10 1.4.1.3 MEDICINAL OILS 10 1.4.1.4 MEDICINAL
SPIRITS 11 1.4.1.5 PLANT JUICES 11 1.4.2 SOLID DOSAGE FORMS 11 1.4.2.1
GRANULES 12 1.4.2.2 UNCOATED TABLETS 12 1.4.2.3 COATED TABLETS 12
1.4.2.4 CAPSULES 12 1.4.2.5 LOZENGES 13 1.4.3 PACKAGING , 13 1.4.4
HERBAL COMBINATION PRODUCTS , 14 1.5 PHYTOTHERAPY 16 1.5.1
PHARRIIACOLOGIC CHARACTERISTICS 16 1.5.1.1 THERAPEUTIC RANGE 16 1.5.1.2
ONSET OF ACTION 16 ,1.5.2 .-PHARMACOLOGIC AND CLINICAL RESEARCH 17
1.5.3 INDICATIONS FOR THE USE OF PHYTOMEDICINES 19 1.5.4 WHAT PHYSICIANS
REQUIRE FROM PHYTOMEDICINES . . 20 1.55 HOPES AND EXPECTATIONS OF THE
PATIENTS 22 1.5.6 BENEFITS AND RISKS OF PHYTOMEDICINES COMPARED WITH
OTHER THERAPIES 23 XI 1.6 MEDICINAL TEAS TODAY 25 1.6.1 ORIGIN OF THE
WORD TEA. MEDICINAL AND NONMEDICINAL TEAS 25 1.6.2 MEDICINAL TEAS AND
THEIR ACTIONS 27 1.6.3 VARIOUS FORMS OF MEDICINAL TEAS 30 1.6.3.1
MIXTURES OF CUT AND DRIED HERBS 31 1.6.3.2 TEA-BAG TEAS 31 1.6.3.3
SOLUBLE TEAS 31 1.6.4 STANDARD APPROVAL FOR TEA MIXTURES 31 1.6.5 TEAS
COMPOUNDED AS PRESCRIBED BY A PHYSICIAN . . 32 1.6.6 GUIDELINES FOR TEA
PREPARATION 34 1.6.7 TEAS FOR INFANTS AND CHILDREN 35 1.6.8 ADVERSE
EFFECTS AND RISKS . 36 2 CENTRAL NERVOUS SYSTEM 41 2.1 GINKGO IN THE
TREATMENT OF COGNITIVE DEFICIENCY 42 2.1.1 INTRODUCTION 42 2.1.2
BOTANICAL DESCRIPTION 43 2.1.3 CRUDE DRUG AND EXTRACT 44 2.1.4 KEY
CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . 44 2.1.5 PHARMACOLOGY AND
TOXICOLOGY 45 2.1.6 CLINICAL EFFICACY IN PATIENTS WITH COGNITIVE
DEFICIENCY 46 2.1.7 INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS
52 2.1.8 THERAPEUTIC SIGNIFICANCE 53 2.1.9 DRUG PRODUCTS 54 2.2 ST.
JOHN'S WORT AS AN ANTIDEPRESSANT 57 2.2.1 INTRODUCTION 57 2.2.2
BOTANICAL DESCRIPTION 57 2.23" ~ CRUDE DRUG AND EXTRACT 58 2.2.4 KEY
CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . 59 2.2.5 PHARMACOLOGY 6L
2.2.5.1 BIOCHEMICAL MODELS 6L 2.2.5.2 BEHAVIORAL MODELS IN ANIMALS 63
2.2.6 TOXICOLOGY, PHOTOSENSITIZATION 64 2.2.7 CLINICAL EFFICACY IN
DEPRESSED PATIENTS 64 2.2.8 INDICATIONS,-'DOSAGES, RISKS, AND
CONTRAINDICATIONS 70 2.2.9 , THERAPEUTIC SIGNIFICANCE 72 2.2.10 * / DRUG
PRODUCTS 73 2.3 KAVA AS AN ANXIOLYTIC 78 2.3.1 INTRODUCTION 78 2.3.2
BOTANICAL DESCRIPTION 78 2.3.3 CRUDE DRUG AND EXTRACT 78 XII TABLE OF
CONTENTS 2.3.4 KEY CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . 79 2.3.5
PHARMACOLOGY AND TOXICOLOGY 80 2.3.6 CLINICAL EFFICACY 81 2.3.7 SIDE
EFFECTS AND RISKS 84 2.3.8 INDICATIONS AND DOSAGES 85 2.3.9 THERAPEUTIC
SIGNIFICANCE 85 2.3.10 DRUG PRODUCTS 85 2.4 RESTLESSNESS AND SLEEP
DISTURBANCES 87 2.4.1 VALERIAN 87 2.4.1.1 MEDICINAL PLANT 87 2.4.1.2
CRUDE DRUG AND EXTRACT 87 2.4.1.3 KEY CONSTITUENTS, ANALYSIS,
PHARMACOKINETICS . 88 2.4.1.4 PHARMACOLOG Y AND TOXICOLOGY 89 2.4.1.5
PHARMACOLOGIC EFFECTS IN HUMANS AND CLINICAL EFFICACY IN PATIENTS 91
2.4.1.6 INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS 96 2.4.1.7
THERAPEUTIC SIGNIFICANCE 97 2.4.2 HOPS, LEMON BALM, PASSION FLOWER, AND
LAVENDER 97 2.4.2.1 HOP STROBILES AND HOP GLANDS 98 2.4.2.2 BALM LEAVES
99 2.4.2.3 PASSION FLOWER 99 2.4.2.4 LAVENDER 100 2.4.3 SEDATIVE TEAS
102 2.4.4 DRUG PRODUCTS 103 3 CARDIOVASCULAR SYSTEM 107 3.1 HEART
FAILURE AND CORONARY INSUFFICIENCY 107 3.1.1 HAWTHORN 108 3.1.1.1
INTRODUCTION 108 3.1.1.2 MEDICINAL PLANT 109 3.1.1.3 CRUDE DRUG AND
EXTRACT 109 3.1.1.4 KEY CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . . .
109 3.1.1.5 PHARMACOLOGY 110 3.1.1.6 TOXICOLOGY 113 3.1.1.7 CLINICAL
EFFICACY 114 3.1.1.8 INDICATIONS. DOSAGES, RISKS, AND CONTRAINDICATIONS
117 3.1.1.9 THERAPEUTIC SIGNIFICANCE 118 3.1.1.10 DRUG PRODUCTS 118
3.1.2 HERBS CONTAINING DIGITALOIDS 119 3,.1.2.1 FALSE HELLABORE 120
4.\22 LILY-OF-THE-VALLEY 120 3.1.2.3 SQUILL POWDER 121 3.1.2.4 OLEANDER
LEAVES 121 3-1.2.5 DRUG PRODUCTS 122 3.1.3 OTHER CARDIOACTIVE PLANT
DRUGS . . . . 122 TABLE OF CONTENTS XIII 3.2 HYPOTENSION AND
HYPERTENSION 124 3.2.1 PHYTOTHERAPY OF HYPOTENSION 124 3.2.1.1
CAFFEINE-CONTAINING HERBS AND BEVERAGES 125 3.2.1.2 ESSENTIAL OILS 126
3.2.2 PHYTOTHERAPY OF HYPERTENSION 126 3.3 ATHEROSCLEROSIS AND ARTERIAL
OCCLUSIVE DISEASE . . 128 3.3.1 GARLIC 128 3.3.1.1 HISTORICAL BACKGROUND
128 3.3.1.2 BOTANICAL DESCRIPTION 129 3.3.1.3 CRUDE DRUG 130 3.3.1.4 KEY
CONSTITUENTS, ANALYSIS, PHARMACOKINETICS . . . 131 3-3.1-5 EXPERIMENTAL
PHARMACOLOGY 133 3.3.1.5.1 EFFECTS ON ATHEROGENESIS AND LIPID METABOLISM
135 3-3.1.5.2 EFFECTS ON VASCULAR RESISTANCE, FIBRINOLYSIS, AND PLATELET
AGGREGATION 135 3.3-1-5.3 CARDIOPROTECTIVE AND ANTIOXIDATIVE EFFECTS 137
3.3-1-5.4 OTHER ACTIONS 137 3.3^1-6 TOXICOLOGY 138 3-3-1-7 CLINICAL
STUDIES 138 3.3.1.7.1 REDUCTION OF ELEVATED BLOOD LIPIDS 140 3.3.1.7.2
BLOOD PRESSURE REDUCTION 141 3.3.1.7.3 INHIBITING THE PROGRESSION OF
ATHEROSCLEROSIS IN HUMANS 142 3.3-1.7.4 OTHER CLINICAL STUDIES 144
3.3.1.8 SIDE EFFECTS AND GARLIC ODOR 144 3.3.1.9 INDICATIONS, DOSAGES,
RISKS, AND CONTRAINDICATIONS 146 3.3.1.10 THERAPEUTIC SIGNIFICANCE 147
3-3-1.11 DRUG PRODUCTS 148 3.3.2 GINGKO SPECIAL EXTRACT FOR PERIPHERAL
ARTERIAL OCCLUSIVE DISEASE 152 3R3-3 OTHER HERBS WITH
ANTIATHEROSCLEROTIC PROPERTIES 155 3-3-3.1 RED YEAST RICE 156 3.4
CHRONIC VENOUS INSUFFICIENCY 158 3.4.1 HORSE CHESTNUT SEED EXTRACT 158
3.4.1.1 INTRODUCTION 158 3.4.1.2 CRUDE DRUG-AND EXTRACT 159 3.4.1.3
CHEMISTRY AND PHARMACOKINETICS OF AESCIN 160 3:4.1.4 PHARMACOLOGY 160
3.4.1.5/' TOXICOLOGY 161 3.4.176 ACTIONS AND EFFICACY IN SUBJECTS AND
PATIENTS . . . 161 3.4.1.6.1 STUDIES IN HEALTHY SUBJECTS 161 3.4.1.6.2
THERAPEUTIC STUDIES IN PATIENTS 161 3.4.1.7 INDICATIONS, DOSAGES, RISKS,
AND CONTRAINDICATIONS 165 XIV TABLE OF CONTENTS 3.4.1.8 THERAPEUTIC
SIGNIFICANCE 165 3.4.2 TOPICAL VENOUS REMEDIES 166 3.4.3 DRUG PRODUCTS
167 4 RESPIRATORY SYSTEM 169 4.1 COLD SYNDROME (FLULIKE INFECTION) 169
4.1.1 RISK FACTORS 169 4.1.2 VIRUSES AND HOST DEFENSES 170 4.2 GENERAL
PHYTOTHERAPEUTIC MEASURES 171 4.2.1 TEAS FOR COLD RELIEF 171 4.2.1.1
ELDER FLOWERS 171 4.2.1.2 LINDEN FLOWERS 172 4.2.1.3 MEADOWSWEET FLOWERS
173 4.2.1.4 WILLOW BARK AND SALICYLATES 174 4.2.1.5 TEA FORMULAS 174
4.2.2 ESSENTIAL OILS 176 4.2.2.1 NASAL OINTMENTS AND NOSEDROPS 176
4.2.2.2 INHALATION THERAPY 177 4.2.2.3 LOZENGES, TROCHES AND GARGLES 178
4.3 HERBAL COUGH REMEDIES 180 4.3.1 MUCILAGINOUS HERBS 180 4.3.2
ESSENTIAL OILS IN COUGH REMEDIES 181 4.3-3 EPHEDRA 182 4.4 HERBAL
EXPECTORANTS 18 4 4.4.1 MECHANISMS OF ACTION 184 4.4.1.1 REDUCTION OF
MUCUS VISCOSITY BY WATER 184 4.4.1.2 NEURAL MECHANISM BASED ON THE
GASTROPULMONARY REFLEX 185 4.4.1.3 LIQUEFACTION OF SECRETIONS BY DIRECT
ACTION ON THE BRONCHIAL GLANDS 185 4.4.2 SAPONIN-CONTAINING HERBS 186
4.4.3 ESSENTIAL OILS AS EXPECTORANTS 189 4.4.3.1 DOSAGE FORMS 190
4.4.3.2 CINEOLE (EUCALYPTOL) 192 4.4.3.3 MYRTOL 192 4.4.3.4 ANISE OIL
AND ANETHOLE 193 4.4.4 LICORICE ROOT 194 4.4.5 SUGGESTED FORMULATIONS
195 4.5 PHYTOTHERAPY OF SINUSITIS 197 -4.6 DRUG PRODUCTS 198 TABLE OF
CONTENTS XV 5 DIGESTIVE SYSTEM 203 5.1 ANOREXIA AND DYSPEPSIA 203 5.1.1
INTRODUCTION 203 5.1.2 BITTER HERBS (BITTERS) 204 5.1.2.1 "WORMWOOD
(ABSINTH) 206 5.1.2.2 OTHER BITTER HERBS 207 5.1.3 BILIARY REMEDIES
(CHOLAGOGUES) 209 5.1.3.1 ARTICHOKE LEAVES 210 5.1.3.2 OTHER CHOLAGOGUES
213 5.1.4 DIGESTIVE ENZYMES 214 5.1.5 SUGGESTED FORMULATIONS 215 5.1.6
DRUG PRODUCTS 217 5.2 BLOATING AND FLATULENCE 218 5.2.1 DEFINITION AND
ACTIONS OF CARMINATIVES 219 5.2.2 TYPICAL CARMINATIVE HERBS 219 5.2.3
SUGGESTED FORMULATIONS 220 5.3 GASTRITIS AND ULCER DISEASE 222 5.3.1
CHAMOMILE 223 5.3.2 LICORICE ROOT 223 5.3.3 DRUG PRODUCTS 224 5.4
IRRITABLE BOWEL SYNDROME 225 5.4.1 SYMPTOMS, EPIDEMIOLOGY, AND
APPROACHES TO TREATMENT 225 5.4.2 PEPPERMINT 226 5.4.2.1 CRUDE DRUG AND
CONSTITUENTS T : 226 5.4.2.2 PEPPERMINT OIL 226 5.4.2.3 PHARMACOKINETICS
227 5.4.2.4 PHARMACOLOGY 228 5.4.2.5 THERAPEUTIC EFFICACY 228 5.4.2.6
RISKS AND SIDE EFFECTS 239 5.4.2.7 INDICATIONS, DOSAGES, AND
CONTRAINDICATIONS . 230 5.5 ACUTE DIARRHEA 232 5.5.1
TANNIN-CONTAINING HERBS 232 5.5.1.1 GREEN AND BLACK TEA 233 5.5.1.2
OTHER TANNIN-CONTAINING HERBS 234 5.5.1.3 TANNIC ACID AND ALBUMIN
TANNATE 235 5.5.2 PECTINS . ; :-. 236 5.5.3 LIVE DRIED YEAST 236 5.5.3-1
PHARMACOLOGY AND TOXICOLOGY 237 5.5.3.2 THERAPEUTIC EFFICACY 237 5.5.3-3
INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS 238 5.5.4 OTHER
HERBAL ANTIDIARRHEALS 238 5.5.5 SUGGESTED FORMULATIONS 240 XVI TABLE OF
CONTENTS 5.6 CONSTIPATION 241 5.6.1 SYMPTOMS, CAUSES, GENERAL MEASURES
241 5.6.2 BULK-FORMING AGENTS 242 5.6.2.1 MECHANISM OF ACTION 242
5.6.2.2 LINSEED 244 5.6.2.3 WHEAT BRAN 246 5.6.2.4 PSYLLIUM SEED AND
HUSK 247 5.6.2.5 AGAR AND KARAYA GUM 248 5.6.3 OSMOTIC AGENTS 248 5.6.4
ANTHRANOID-CONTAINING HERBS 249 5.6.4.1 RHUBARB ROOT 251 5.6.4.2
BUCKTHORN BARK 252 5.6.4.3 SENNA PODS AND LEAVES 253 5.6.4.4 ALOE 253
5.6.5 CASTOR OIL 254 5.6.6 SUGGESTED FORMULATIONS 255 5.7 LIVER DISEASES
257 5.7.1 MILK THISTLE FRUITS, SILYMARIN 258 5.7.1.1 MEDICINAL PLANT AND
CRUDE DRUG 258 5.7.1.2 COMPONENTS AND ACTIVE CONSTITUENTS 259 5.7.1.3
PHARMACOKINETICS 259 5.7.1.4 PHARMACOLOGY AND TOXICOLOGY 259 5.7.1.5
THERAPEUTIC EFFICACY IN CHRONIC LIVER DISEASES . . 260 5.7.1.6 USE IN
MUSHROOM POISONING 261 5.7.1.7 INDICATIONS, DOSAGES, RISKS, AND
CONTRAINDICATIONS 262 5.7.2 SOYBEAN PHOSPHOLIPIDS 262 5.7.3 DRUG
PRODUCTS 263 6 URINARY TRACT 265 6.1 INFLAMMATORY DISEASES OF THE
URINARY TRACT . 265 6.1.1 UVA URSI LEAVES 266 6.1.2 PETASITE RHIZOME
268 6.2 BENIGN PROSTATIC HYPERPLASIA 268 6.2.1 SAW PALMETTO BERRIES 270
6.2.2 NETTLE ROOT 274 6.2.3 PUMPKIN SEEDS 275 6.2.4 GRASS POLLENS 276
6.2.5 PHYTOSTEROLS FROM HYPOXIS ROOPERI 277 6.2.6 PYGEUM 278 / '6.3
THERAPEUTIC SIGNIFICANCE 278 6.4 DRUG PRODUCTS OTHER THAN TEAS 27 9 6.5
BLADDER AND KIDNEY TEAS 280 TABLE OF CONTENTS XVII 7. GYNECOLOGIC
INDICATIONS FOR HERBAL REMEDIES . . . 285 7.1 CHASTEBERRY 286 7.2 BLACK
COHOSH 289 7.3 PHYTOESTROGENS 291 7.4 OTHER HERBS 293 7.5 THERAPEUTIC
SIGNIFICANCE 295 7.6 DRUG PRODUCTS 295 8 SKIN,TRAUMA, RHEUMATISM, AND
PAIN 299 8.1 DOSAGE FORMS AND PREPARATIONS 299 8.2 INFLAMMATIONS AND
INJURIES OF THE SKIN 301 8.2.1 CHAMOMILE FLOWERS 301 8.2.1.1 CRUDE DRUG,
CONSTITUENTS, AND PREPARATIONS . 302 8.2.1.2 PHARMACOLOGY AND
TOXICOLOGY 304 8.2.1.3 THERAPEUTIC EFFICACY 305 8.2.1.4 INDICATIONS,
DOSAGES, SIDE EFFECTS, AND RISKS . 305 8.2.2 WITCH HAZEL AND OTHER
TANNIN-CONTAINING HERBS 306 8.2.3 EVENING PRIMROSE OIL 308 8.2.4 OTHER
DERMATOLOGIC HERBS 310 8.3 POST-TRAUMATIC AND POSTOPERATIVE CONDITIONS .
. . 313 8.3.1 BROMELAIN 313 8.3.2 COMFREY 314 8.3.3 ARNICA 314 8.4
RHEUMATIC CONDITIONS AND DEGENERATIVE JOINT DISEASES 316 8.4.1 " DEVIL'S
CLAW 316 8.4.2 WILLOW BARK, ASH, ASPEN 318 8.4.3 NETTLE TOPS 319 8.4.4
BOSWELLIA SERRATA 319 8.5 TREATMENT OF PAIN 320 8.5.1 PEPPERMINT OIL AND
TENSION HEADACHE 320 8.5.2 CAPSICUM (PAPRIKA) FOR LOCAL PAIN RELIEF 322
8.6, FORMULATIONS 325 8.7 / DRUG PRODUCTS 326 XVIII TABLE OF CONTENTS 9
AGENTS THAT INCREASE RESISTANCE TO DISEASES . 331 9.1 ADAPTOGENS 331
9.1.1 GINSENG 332 9.1.1.1 PLANT, CRUDE DRUG, AND CONSTITUENTS 332
9.1.1.2 PHARMACOLOGY AND TOXICOLOGY 333 9.1.1.3 CLINICAL STUDIES IN
HUMANS 334 9.1-1.4 INDICATIONS, DOSAGES, RISKS, AND CONTRAINDICATIONS
334 9.1.2 ELEUTHEROCOCCUS ROOT 335 9.1-3 OTHER ADAPTOGENIC DRUGS 336
9.1.3.1 CORDYCEPS 336 9.1.3.2 ASHWAGANDHA 337 9.1.3.3 GOTU KOLA 337
9.1.3.4 ASTRAGALUS 338 9.1.3.5 CAT'S CLAW 338 9-1.3.6 BOTANICAL
ANTIOXIDANTS (GRAPE SEED, GREEN TEA, PINE BARK) 339 9-1-3.6.1
PHARMACOLOGY AND TOXICOLOGY 339 9-1-3.6.2 CLINICAL AND EPIDEMIOLOGICAL
STUDIES 340 9-1-3.6.3 INDICATIONS AND DOSAGE 341 9.2 IMMUNE STIMULANTS
341 9.2.1 CONEFLOWER (ECHINACEA) 342 9.2.1.1 PLANT, CRUDE DRUG, AND
CONSTITUENTS 342 9.2.1.2 PHARMACOLOGY AND TOXICOLOGY 343 9-2.1.3 STUDIES
ON THERAPEUTIC EFFICACY 344 9-2.1.4 INDICATIONS, DOSAGES, AND RISKS 346
9.2.2 EUROPEAN MISTLETOE 347 9.2.2.1 PLANT, CONSTITUENTS, AND ACTIONS
347 9.2.2.2 CLINICAL EFFICACY STUDIES 349 9.2.2.3 INDICATIONS, DOSAGES,
AND RISKS 350 9.2.3 MEDICINAL YEASTS 350 '9.2.4 GOLDENSEAL 351 9.3
THERAPEUTIC SIGNIFICANCE 352 10 APPENDIX THE 100 MOST COMMONLY
PRESCRIBED HERBAL MEDICATIONS IN GERMANY 357 SUBJECT INDEX 369 TABLE OF
CONTENTS XIX |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Schulz, Volker 1942- Hänsel, Rudolf 1920-2018 Tyler, Varro E. |
| author_GND | (DE-588)1070874647 (DE-588)115453075 |
| author_facet | Schulz, Volker 1942- Hänsel, Rudolf 1920-2018 Tyler, Varro E. |
| author_role | aut aut aut |
| author_sort | Schulz, Volker 1942- |
| author_variant | v s vs r h rh v e t ve vet |
| building | Verbundindex |
| bvnumber | BV021788672 |
| callnumber-first | R - Medicine |
| callnumber-label | RM666 |
| callnumber-raw | RM666.H33 |
| callnumber-search | RM666.H33 |
| callnumber-sort | RM 3666 H33 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VS 9450 |
| ctrlnum | (OCoLC)44267919 (DE-599)BVBBV021788672 |
| dewey-full | 615/.321 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.321 |
| dewey-search | 615/.321 |
| dewey-sort | 3615 3321 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| discipline_str_mv | Chemie / Pharmazie Medizin |
| edition | 4. ed., fully rev. and expanded |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02178nam a2200565 c 4500</leader><controlfield tag="001">BV021788672</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150512 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">061030s2001 gw a||| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">959084703</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540670963</subfield><subfield code="c">Pp. : DM 78.00</subfield><subfield code="9">3-540-67096-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)44267919</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021788672</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="1" ind2=" "><subfield code="a">eng</subfield><subfield code="h">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.H33</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.321</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9450</subfield><subfield code="0">(DE-625)147729:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schulz, Volker</subfield><subfield code="d">1942-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1070874647</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rational phytotherapy</subfield><subfield code="b">a physicians' guide to herbal medicine</subfield><subfield code="c">Volker Schulz ; Rudolf Hänsel ; Varro E. Tyler</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">4. ed., fully rev. and expanded</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIX, 383 S.</subfield><subfield code="b">Ill., graph,Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben. - Dt. Ausg. u.d.T.: Schulz, Volker: Rationale Phytotherapie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Extraits de plantes - usage thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herbes - Emploi en thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Phytothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phytothérapie</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Plantes médicinales</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Plantes médicinales</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herbal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Herbs</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Plant Extracts</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Plants, Medicinal</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Phytotherapie</subfield><subfield code="0">(DE-588)4045998-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Phytopharmakon</subfield><subfield code="0">(DE-588)4115561-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Phytopharmakon</subfield><subfield code="0">(DE-588)4115561-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Phytotherapie</subfield><subfield code="0">(DE-588)4045998-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hänsel, Rudolf</subfield><subfield code="d">1920-2018</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)115453075</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tyler, Varro E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015001354&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015001354</subfield></datafield></record></collection> |
| id | DE-604.BV021788672 |
| illustrated | Illustrated |
| index_date | 2024-07-02T15:43:46Z |
| indexdate | 2024-07-09T20:44:38Z |
| institution | BVB |
| isbn | 3540670963 |
| language | English German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015001354 |
| oclc_num | 44267919 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XIX, 383 S. Ill., graph,Darst. |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | Springer |
| record_format | marc |
| spelling | Schulz, Volker 1942- Verfasser (DE-588)1070874647 aut Rational phytotherapy a physicians' guide to herbal medicine Volker Schulz ; Rudolf Hänsel ; Varro E. Tyler 4. ed., fully rev. and expanded Berlin [u.a.] Springer 2001 XIX, 383 S. Ill., graph,Darst. txt rdacontent n rdamedia nc rdacarrier Literaturangaben. - Dt. Ausg. u.d.T.: Schulz, Volker: Rationale Phytotherapie Extraits de plantes - usage thérapeutique Herbes - Emploi en thérapeutique Phytothérapie Phytothérapie ram Plantes médicinales Plantes médicinales ram Herbal Medicine Herbs Therapeutic use Plant Extracts therapeutic use Plants, Medicinal Phytotherapie (DE-588)4045998-6 gnd rswk-swf Phytopharmakon (DE-588)4115561-0 gnd rswk-swf Phytopharmakon (DE-588)4115561-0 s DE-604 Phytotherapie (DE-588)4045998-6 s Hänsel, Rudolf 1920-2018 Verfasser (DE-588)115453075 aut Tyler, Varro E. Verfasser aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015001354&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Schulz, Volker 1942- Hänsel, Rudolf 1920-2018 Tyler, Varro E. Rational phytotherapy a physicians' guide to herbal medicine Extraits de plantes - usage thérapeutique Herbes - Emploi en thérapeutique Phytothérapie Phytothérapie ram Plantes médicinales Plantes médicinales ram Herbal Medicine Herbs Therapeutic use Plant Extracts therapeutic use Plants, Medicinal Phytotherapie (DE-588)4045998-6 gnd Phytopharmakon (DE-588)4115561-0 gnd |
| subject_GND | (DE-588)4045998-6 (DE-588)4115561-0 |
| title | Rational phytotherapy a physicians' guide to herbal medicine |
| title_auth | Rational phytotherapy a physicians' guide to herbal medicine |
| title_exact_search | Rational phytotherapy a physicians' guide to herbal medicine |
| title_exact_search_txtP | Rational phytotherapy a physicians' guide to herbal medicine |
| title_full | Rational phytotherapy a physicians' guide to herbal medicine Volker Schulz ; Rudolf Hänsel ; Varro E. Tyler |
| title_fullStr | Rational phytotherapy a physicians' guide to herbal medicine Volker Schulz ; Rudolf Hänsel ; Varro E. Tyler |
| title_full_unstemmed | Rational phytotherapy a physicians' guide to herbal medicine Volker Schulz ; Rudolf Hänsel ; Varro E. Tyler |
| title_short | Rational phytotherapy |
| title_sort | rational phytotherapy a physicians guide to herbal medicine |
| title_sub | a physicians' guide to herbal medicine |
| topic | Extraits de plantes - usage thérapeutique Herbes - Emploi en thérapeutique Phytothérapie Phytothérapie ram Plantes médicinales Plantes médicinales ram Herbal Medicine Herbs Therapeutic use Plant Extracts therapeutic use Plants, Medicinal Phytotherapie (DE-588)4045998-6 gnd Phytopharmakon (DE-588)4115561-0 gnd |
| topic_facet | Extraits de plantes - usage thérapeutique Herbes - Emploi en thérapeutique Phytothérapie Plantes médicinales Herbal Medicine Herbs Therapeutic use Plant Extracts therapeutic use Plants, Medicinal Phytotherapie Phytopharmakon |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015001354&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT schulzvolker rationalphytotherapyaphysiciansguidetoherbalmedicine AT hanselrudolf rationalphytotherapyaphysiciansguidetoherbalmedicine AT tylervarroe rationalphytotherapyaphysiciansguidetoherbalmedicine |